According to the research report, the global market for Oral Cholera Vaccine should grow from US$ 85 million in 2022 to US$ 146.3 million by 2029, with a CAGR of 7.5% for the period of 2023-2029.
Global top four manufacturers of oral cholera vaccine include EuBiologics, Sanofi, United Biotech and Vabiotech, etc. The leading player is EuBiologics, who makes up over 40%.
South Korea is the largest producer, with a market share more than 80%, followed by India (10%). Mid East & Africa gains the segment, with a share about 30%.
Euvichol-Plus is the key segment among three types of oral cholera vaccine, accounting for over 40%. In terms of application, main uses of oral cholera vaccine are preventive campaigns and outbreak response.
This report aims to provide a comprehensive study of the global market for Oral Cholera Vaccine. Key Takeaways and Highlights
(1) Global Oral Cholera Vaccine market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Oral Cholera Vaccine market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Oral Cholera Vaccine market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Oral Cholera Vaccine segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Oral Cholera Vaccine segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Oral Cholera Vaccine, capacity, production and trends.
(7) Oral Cholera Vaccine industry supply chain, upstream, midstream and downstream analysis.
Regional Breakdown: Analyzing Market Segments by Geography
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Segmenting by Type: Comprehensive Coverage and Analysis
Euvichol-Plus
DUKORAL
Shanchol
Others
Application-Based Segmentation: Unlocking Market Opportunities
Preventive Campaigns
Outbreak Response
In the Spotlight: A Closer Look at Market Players
PaxVax
Sanofi
Valneva
EuBiologics
United Biotech
Vabiotech
PaxVax
1 Market Overview
1.1 Oral Cholera Vaccine Definition
1.2 Global Oral Cholera Vaccine Market Size and Forecast
1.2.1 By Revenue, Global Oral Cholera Vaccine Market Size, 2018-2029
1.2.2 By Sales Volume, Global Oral Cholera Vaccine Market Size, 2018-2029
1.2.3 Global Oral Cholera Vaccine Price Trend, 2018-2029
1.3 China Oral Cholera Vaccine Market Size and Forecast
1.3.1 By Revenue, China Oral Cholera Vaccine Market Size, 2018-2029
1.3.2 By Sales Volume, China Oral Cholera Vaccine Market Size, 2018-2029
1.3.3 China Oral Cholera Vaccine Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Oral Cholera Vaccine Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Oral Cholera Vaccine Share in Global Market, 2018-2029
1.4.3 Oral Cholera Vaccine Market Size: China VS Global, 2018-2029
1.5 Oral Cholera Vaccine Market Dynamics
1.5.1 Oral Cholera Vaccine Market Drivers
1.5.2 Oral Cholera Vaccine Market Restraints
1.5.3 Oral Cholera Vaccine Industry Trends
1.5.4 Oral Cholera Vaccine Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Oral Cholera Vaccine Revenue by Company, 2018-2023
2.2 Global Oral Cholera Vaccine Sales Volume by Company, 2018-2023
2.3 Global Oral Cholera Vaccine Price by Company, 2018-2023
2.4 Global Oral Cholera Vaccine Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Oral Cholera Vaccine Concentration Ratio
2.6 Global Oral Cholera Vaccine Mergers & Acquisitions, Expansion Plans
2.7 Global Oral Cholera Vaccine Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Oral Cholera Vaccine Revenue by Company, 2018-2023
3.2 China Oral Cholera Vaccine Sales Volume by Company, 2018-2023
3.3 China Oral Cholera Vaccine Oral Cholera Vaccine Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Oral Cholera Vaccine Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Oral Cholera Vaccine Domestic VS Export
3.6 China Market, Oral Cholera Vaccine Import & Export
3.6.1 China Market, Oral Cholera Vaccine Import & Export, 2018-2029
3.6.2 China Oral Cholera Vaccine Import & Export Trends
3.6.3 Main Sources of China Oral Cholera Vaccine Import
3.6.4 Export Destination of China Oral Cholera Vaccine
4 Oral Cholera Vaccine Production by Region
4.1 Global Oral Cholera Vaccine Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Oral Cholera Vaccine Manufacturers
4.3 Global Major Manufacturers, Oral Cholera Vaccine Capacity Expansion and Future Plans
4.4 Global Oral Cholera Vaccine Capacity by Region
4.5 Global Oral Cholera Vaccine Production by Region
4.5.1 Global Oral Cholera Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Oral Cholera Vaccine Production by Region, 2018-2023
4.5.3 Global Oral Cholera Vaccine Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Oral Cholera Vaccine Industry Chain
5.2 Oral Cholera Vaccine Upstream Analysis
5.2.1 Oral Cholera Vaccine Core Raw Materials
5.2.2 Main Manufacturers of Oral Cholera Vaccine Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Oral Cholera Vaccine Production Mode
5.6 Oral Cholera Vaccine Procurement Model
5.7 Oral Cholera Vaccine Industry Sales Model and Sales Channels
5.7.1 Oral Cholera Vaccine Sales Model
5.7.2 Oral Cholera Vaccine Typical Distributors
6 Sights by Type
6.1 Oral Cholera Vaccine Classification
6.1.1 Euvichol-Plus
6.1.2 DUKORAL
6.1.3 Shanchol
6.1.4 Others
6.2 By Type, Global Oral Cholera Vaccine Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Oral Cholera Vaccine Revenue, 2018-2029
6.4 By Type, Global Oral Cholera Vaccine Sales Volume, 2018-2029
6.5 By Type, Global Oral Cholera Vaccine Price, 2018-2029
7 Sights by Application
7.1 Oral Cholera Vaccine Segment by Application
7.1.1 Preventive Campaigns
7.1.2 Outbreak Response
7.2 By Application, Global Oral Cholera Vaccine Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Oral Cholera Vaccine Revenue, 2018-2029
7.4 By Application, Global Oral Cholera Vaccine Sales Volume, 2018-2029
7.5 By Application, Global Oral Cholera Vaccine Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Oral Cholera Vaccine Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Oral Cholera Vaccine Revenue, 2018-2029
8.3 By Region, Global Oral Cholera Vaccine Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Oral Cholera Vaccine Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Oral Cholera Vaccine Market Size Market Share
8.5 Europe
8.5.1 Europe Oral Cholera Vaccine Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Oral Cholera Vaccine Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Oral Cholera Vaccine Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Oral Cholera Vaccine Market Size Market Share
8.7 South America
8.7.1 South America Oral Cholera Vaccine Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Oral Cholera Vaccine Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Oral Cholera Vaccine Market Size & CAGR,2018 VS 2022 VS 2029
9.2 By Country, Global Oral Cholera Vaccine Revenue, 2018-2029
9.3 By Country, Global Oral Cholera Vaccine Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Oral Cholera Vaccine Market Size, 2018-2029
9.4.2 By Company, U.S. Oral Cholera Vaccine Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Oral Cholera Vaccine Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Oral Cholera Vaccine Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Oral Cholera Vaccine Market Size, 2018-2029
9.5.2 By Company, Europe Oral Cholera Vaccine Sales Volume Market Share, 2022
9.5.3 By Type, Europe Oral Cholera Vaccine Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Oral Cholera Vaccine Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Oral Cholera Vaccine Market Size, 2018-2029
9.6.2 By Company, China Oral Cholera Vaccine Sales Volume Market Share, 2022
9.6.3 By Type, China Oral Cholera Vaccine Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Oral Cholera Vaccine Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Oral Cholera Vaccine Market Size, 2018-2029
9.7.2 By Company, Japan Oral Cholera Vaccine Sales Volume Market Share, 2022
9.7.3 By Type, Japan Oral Cholera Vaccine Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Oral Cholera Vaccine Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Oral Cholera Vaccine Market Size, 2018-2029
9.8.2 By Company, South Korea Oral Cholera Vaccine Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Oral Cholera Vaccine Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Oral Cholera Vaccine Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Oral Cholera Vaccine Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Oral Cholera Vaccine Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Oral Cholera Vaccine Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Oral Cholera Vaccine Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Oral Cholera Vaccine Market Size, 2018-2029
9.10.2 By Company, India Oral Cholera Vaccine Sales Volume Market Share, 2022
9.10.3 By Type, India Oral Cholera Vaccine Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Oral Cholera Vaccine Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Oral Cholera Vaccine Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Oral Cholera Vaccine Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Oral Cholera Vaccine Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Oral Cholera Vaccine Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 PaxVax
10.1.1 PaxVax Company Information, Head Office, Market Area and Industry Position
10.1.2 PaxVax Oral Cholera Vaccine Models, Specifications and Application
10.1.3 PaxVax Oral Cholera Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 PaxVax Company Profile and Main Business
10.1.5 PaxVax Recent Developments
10.2 Sanofi
10.2.1 Sanofi Company Information, Head Office, Market Area and Industry Position
10.2.2 Sanofi Oral Cholera Vaccine Models, Specifications and Application
10.2.3 Sanofi Oral Cholera Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Sanofi Company Profile and Main Business
10.2.5 Sanofi Recent Developments
10.3 Valneva
10.3.1 Valneva Company Information, Head Office, Market Area and Industry Position
10.3.2 Valneva Oral Cholera Vaccine Models, Specifications and Application
10.3.3 Valneva Oral Cholera Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Valneva Company Profile and Main Business
10.3.5 Valneva Recent Developments
10.4 EuBiologics
10.4.1 EuBiologics Company Information, Head Office, Market Area and Industry Position
10.4.2 EuBiologics Oral Cholera Vaccine Models, Specifications and Application
10.4.3 EuBiologics Oral Cholera Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 EuBiologics Company Profile and Main Business
10.4.5 EuBiologics Recent Developments
10.5 United Biotech
10.5.1 United Biotech Company Information, Head Office, Market Area and Industry Position
10.5.2 United Biotech Oral Cholera Vaccine Models, Specifications and Application
10.5.3 United Biotech Oral Cholera Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 United Biotech Company Profile and Main Business
10.5.5 United Biotech Recent Developments
10.6 Vabiotech
10.6.1 Vabiotech Company Information, Head Office, Market Area and Industry Position
10.6.2 Vabiotech Oral Cholera Vaccine Models, Specifications and Application
10.6.3 Vabiotech Oral Cholera Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Vabiotech Company Profile and Main Business
10.6.5 Vabiotech Recent Developments
10.7 PaxVax
10.7.1 PaxVax Company Information, Head Office, Market Area and Industry Position
10.7.2 PaxVax Oral Cholera Vaccine Models, Specifications and Application
10.7.3 PaxVax Oral Cholera Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 PaxVax Company Profile and Main Business
10.7.5 PaxVax Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Oral Cholera Vaccine Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Oral Cholera Vaccine Market Restraints
Table 3. Oral Cholera Vaccine Market Trends
Table 4. Oral Cholera Vaccine Industry Policy
Table 5. Global Oral Cholera Vaccine Revenue by Company, 2018-2023, US$ million
Table 6. Global Oral Cholera Vaccine Revenue Market Share by Company, 2018-2023
Table 7. Global Oral Cholera Vaccine Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Oral Cholera Vaccine Sales Volume Market Share by Company, 2018-2023
Table 9. Global Oral Cholera Vaccine Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Oral Cholera Vaccine Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Oral Cholera Vaccine Mergers & Acquisitions, Expansion Plans
Table 12. Global Oral Cholera Vaccine Manufacturers Product Type
Table 13. China Oral Cholera Vaccine Revenue by Company, 2018-2023, US$ million
Table 14. China Oral Cholera Vaccine Revenue Market Share by Company, 2018-2023
Table 15. China Oral Cholera Vaccine Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Oral Cholera Vaccine Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Oral Cholera Vaccine Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Oral Cholera Vaccine Import & Export Trends
Table 19. Main Sources of China Oral Cholera Vaccine Import
Table 20. Export Destination of China Oral Cholera Vaccine
Table 21. Global Headquarters and Manufacturing Base of Oral Cholera Vaccine Manufacturers
Table 22. Global Major Manufacturers, Oral Cholera Vaccine Capacity Expansion and Future Plans
Table 23. Global Oral Cholera Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Oral Cholera Vaccine Production by Region, 2018-2023, (K Units)
Table 25. Global Oral Cholera Vaccine Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Oral Cholera Vaccine Upstream (Raw Materials)
Table 27. Global Oral Cholera Vaccine Typical Customers
Table 28. Oral Cholera Vaccine Typical Distributors
Table 29. By Type, Global Oral Cholera Vaccine Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Oral Cholera Vaccine Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Oral Cholera Vaccine Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Oral Cholera Vaccine Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Oral Cholera Vaccine Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Oral Cholera Vaccine Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Oral Cholera Vaccine Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Oral Cholera Vaccine Revenue Market Share, 2018-2029
Table 37. By Country, Global Oral Cholera Vaccine Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Oral Cholera Vaccine Sales Volume Market Share, 2018-2029
Table 39. PaxVax Company Information, Head Office, Market Area and Industry Position
Table 40. PaxVax Oral Cholera Vaccine Models, Specifications and Application
Table 41. PaxVax Oral Cholera Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. PaxVax Company Profile and Main Business
Table 43. PaxVax Recent Developments
Table 44. Sanofi Company Information, Head Office, Market Area and Industry Position
Table 45. Sanofi Oral Cholera Vaccine Models, Specifications and Application
Table 46. Sanofi Oral Cholera Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Sanofi Company Profile and Main Business
Table 48. Sanofi Recent Developments
Table 49. Valneva Company Information, Head Office, Market Area and Industry Position
Table 50. Valneva Oral Cholera Vaccine Models, Specifications and Application
Table 51. Valneva Oral Cholera Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Valneva Company Profile and Main Business
Table 53. Valneva Recent Developments
Table 54. EuBiologics Company Information, Head Office, Market Area and Industry Position
Table 55. EuBiologics Oral Cholera Vaccine Models, Specifications and Application
Table 56. EuBiologics Oral Cholera Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. EuBiologics Company Profile and Main Business
Table 58. EuBiologics Recent Developments
Table 59. United Biotech Company Information, Head Office, Market Area and Industry Position
Table 60. United Biotech Oral Cholera Vaccine Models, Specifications and Application
Table 61. United Biotech Oral Cholera Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. United Biotech Company Profile and Main Business
Table 63. United Biotech Recent Developments
Table 64. Vabiotech Company Information, Head Office, Market Area and Industry Position
Table 65. Vabiotech Oral Cholera Vaccine Models, Specifications and Application
Table 66. Vabiotech Oral Cholera Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Vabiotech Company Profile and Main Business
Table 68. Vabiotech Recent Developments
Table 69. PaxVax Company Information, Head Office, Market Area and Industry Position
Table 70. PaxVax Oral Cholera Vaccine Models, Specifications and Application
Table 71. PaxVax Oral Cholera Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. PaxVax Company Profile and Main Business
Table 73. PaxVax Recent Developments
List of Figure
Figure 1. Oral Cholera Vaccine Picture
Figure 2. By Revenue, Global Oral Cholera Vaccine Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Oral Cholera Vaccine Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Oral Cholera Vaccine Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Oral Cholera Vaccine Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Oral Cholera Vaccine Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Oral Cholera Vaccine Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Oral Cholera Vaccine Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Oral Cholera Vaccine Share of Global Market, 2018-2029
Figure 10. Global Oral Cholera Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Oral Cholera Vaccine Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Oral Cholera Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Oral Cholera Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Oral Cholera Vaccine Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Oral Cholera Vaccine Domestic VS Export, 2022
Figure 16. Global Oral Cholera Vaccine Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Oral Cholera Vaccine Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Oral Cholera Vaccine Production Market Share & Forecast by Region, 2018-2029
Figure 19. Oral Cholera Vaccine Industry Chain
Figure 20. Oral Cholera Vaccine Procurement Model
Figure 21. Oral Cholera Vaccine Sales Model
Figure 22. Oral Cholera Vaccine Sales Channels, Direct Sales and Distribution
Figure 23. Euvichol-Plus
Figure 24. DUKORAL
Figure 25. Shanchol
Figure 26. Others
Figure 27. By Type, Global Oral Cholera Vaccine Revenue, 2018-2029, US$ Million
Figure 28. By Type, Global Oral Cholera Vaccine Revenue Market Share, 2018-2029
Figure 29. By Type, Global Oral Cholera Vaccine Sales Volume, 2018-2029, (K Units)
Figure 30. By Type, Global Oral Cholera Vaccine Sales Volume Market Share, 2018-2029
Figure 31. By Type, Global Oral Cholera Vaccine Price, 2018-2029, (US$/Unit)
Figure 32. Preventive Campaigns
Figure 33. Outbreak Response
Figure 34. By Application, Global Oral Cholera Vaccine Revenue, 2018-2029, US$ Million
Figure 35. By Application, Global Oral Cholera Vaccine Revenue Market Share, 2018-2029
Figure 36. By Application, Global Oral Cholera Vaccine Sales Volume, 2018-2029, (K Units)
Figure 37. By Application, Global Oral Cholera Vaccine Sales Volume Market Share, 2018-2029
Figure 38. By Application, Global Oral Cholera Vaccine Price, 2018-2029, (US$/Unit)
Figure 39. By Region, Global Oral Cholera Vaccine Revenue Market Share, 2018-2029
Figure 40. By Region, Global Oral Cholera Vaccine Sales Volume Market Share, 2018-2029
Figure 41. North America Oral Cholera Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, North America Oral Cholera Vaccine Revenue Market Share, 2022
Figure 43. Europe Oral Cholera Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 44. By Country, Europe Oral Cholera Vaccine Revenue Market Share, 2022
Figure 45. Asia Pacific Oral Cholera Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 46. By Country/Region, Asia Pacific Oral Cholera Vaccine Revenue Market Share, 2022
Figure 47. South America Oral Cholera Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 48. By Country, South America Oral Cholera Vaccine Revenue Market Share, 2022
Figure 49. Middle East & Africa Oral Cholera Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 50. U.S. Oral Cholera Vaccine Sales Volume, 2018-2029, (K Units)
Figure 51. By Company, U.S. Oral Cholera Vaccine Market Share, 2022
Figure 52. By Type, U.S. Oral Cholera Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 53. By Application, U.S. Oral Cholera Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 54. Europe Oral Cholera Vaccine Sales Volume, 2018-2029, (K Units)
Figure 55. By Company, Europe Oral Cholera Vaccine Market Share, 2022
Figure 56. By Type, Europe Oral Cholera Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 57. By Application, Europe Oral Cholera Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 58. China Oral Cholera Vaccine Sales Volume, 2018-2029, (K Units)
Figure 59. By Company, China Oral Cholera Vaccine Market Share, 2022
Figure 60. By Type, China Oral Cholera Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 61. By Application, China Oral Cholera Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 62. Japan Oral Cholera Vaccine Sales Volume, 2018-2029, (K Units)
Figure 63. By Company, Japan Oral Cholera Vaccine Market Share, 2022
Figure 64. By Type, Japan Oral Cholera Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 65. By Application, Japan Oral Cholera Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 66. South Korea Oral Cholera Vaccine Sales Volume, 2018-2029, (K Units)
Figure 67. By Company, South Korea Oral Cholera Vaccine Market Share, 2022
Figure 68. By Type, South Korea Oral Cholera Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 69. By Application, South Korea Oral Cholera Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 70. Southeast Asia Oral Cholera Vaccine Sales Volume, 2018-2029, (K Units)
Figure 71. By Company, Southeast Asia Oral Cholera Vaccine Market Share, 2022
Figure 72. By Type, Southeast Asia Oral Cholera Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 73. By Application, Southeast Asia Oral Cholera Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 74. India Oral Cholera Vaccine Sales Volume, 2018-2029, (K Units)
Figure 75. By Company, India Oral Cholera Vaccine Market Share, 2022
Figure 76. By Type, India Oral Cholera Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 77. By Application, India Oral Cholera Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 78. Middle East & Asia Oral Cholera Vaccine Sales Volume, 2018-2029, (K Units)
Figure 79. By Company, Middle East & Asia Oral Cholera Vaccine Market Share, 2022
Figure 80. By Type, Middle East & Asia Oral Cholera Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 81. By Application, Middle East & Asia Oral Cholera Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 82. Research Methodology
Figure 83. Breakdown of Primary Interviews
Figure 84. Bottom-up Approaches
Figure 85. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|